## **Core Concept**
Methotrexate is an antifolate drug that interferes with DNA synthesis. It acts by inhibiting an enzyme crucial for the synthesis of thymidine monophosphate (TMP), which is a nucleotide required for DNA replication and repair. This mechanism is critical in rapidly dividing cells, such as cancer cells and certain cells in the bone marrow and gastrointestinal tract.

## **Why the Correct Answer is Right**
The correct answer, **Dihydrofolate reductase (DHFR)**, is the enzyme targeted by methotrexate. DHFR is essential for the regeneration of tetrahydrofolate (THF) from dihydrofolate (DHF). THF is a necessary cofactor for the conversion of deoxyuridine monophosphate (dUMP) to thymidine monophosphate (TMP) by the enzyme thymidylate synthase. By inhibiting DHFR, methotrexate effectively reduces the available pool of THF, which in turn inhibits the synthesis of TMP. This leads to a deficiency in thymidine, impairing DNA synthesis and cell replication.

## **Why Each Wrong Option is Incorrect**
- **Option A (Thymidylate synthase):** This enzyme is involved in the conversion of dUMP to TMP but is not directly inhibited by methotrexate. Instead, its activity is indirectly affected by methotrexate's inhibition of DHFR.
- **Option B (Ribonucleotide reductase):** This enzyme is involved in the conversion of ribonucleotides to deoxyribonucleotides, a step necessary for DNA synthesis. However, it is not the primary target of methotrexate.
- **Option C (DNA polymerase):** This enzyme is crucial for DNA replication and repair but is not directly inhibited by methotrexate.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that methotrexate's effects can be reversed by administering folinic acid (leucovorin), a form of folate that bypasses the blockage caused by methotrexate. This is particularly useful in cases of methotrexate overdose or when trying to minimize its toxic effects on normal tissues.

## **Correct Answer: D. Dihydrofolate reductase**